Payments to Acquire Property, Plant, and Equipment of Apellis Pharmaceuticals, Inc. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Apellis Pharmaceuticals, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • Apellis Pharmaceuticals, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $8,000, a 97% decline year-over-year.
  • Apellis Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $313,000, a 22% decline from 2024.
  • Apellis Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $403,000, a 48% decline from 2023.
  • Apellis Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $773,000, a 49% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Apellis Pharmaceuticals, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $313,000 -$90,000 -22% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 $403,000 -$370,000 -48% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 $773,000 -$751,000 -49% 01 Jan 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
2022 $1,524,000 +$421,000 +38% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
2021 $1,103,000 -$4,319,000 -80% 01 Jan 2021 31 Dec 2021 10-K/A 29 Feb 2024 2023 FY
2020 $5,422,000 +$3,729,000 +220% 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023 2022 FY
2019 $1,693,000 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY

Apellis Pharmaceuticals, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $8,000 -$285,000 -97% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q1 2024 $293,000 +$34,000 +13% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q1 2023 $259,000 +$173,000 +201% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $86,000 -$398,000 -82% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $484,000 +$49,000 +11% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $435,000 -$440,000 -50% 01 Jan 2020 31 Mar 2020 10-Q 28 Apr 2021 2021 Q1
Q1 2019 $875,000 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.